Skip to collection list Skip to video grid
Skip to collection list Skip to video grid

Vaccine/Immunization

Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting

The effectiveness of nirsevimab to prevent medically attended RSV-LRTI in infants in outpatient settings in Valencia and Murcia regions of Spain is 76%.

Click here to read the article
Read More
Read Less

categories

View more in
Vaccine/Immunization

Currently loaded videos are 1 through 15 of 48 total videos.

First page loaded, no previous page available
Load Next Page
4:07
A Bundled, Practice-Based Intervention to Increase HPV Vaccination
A Bundled, Practice-Based Intervention to Increase HPV Vaccination
4:09
Invalid Vaccine Doses Among Children Ages 0-35 months: 2011-2020
Invalid Vaccine Doses Among Children Ages 0-35 months: 2011-2020
4:06
Risk of Transmission of Vaccine-Strain Rotavirus in a NICU that Routinely Vaccinates
Risk of Transmission of Vaccine-Strain Rotavirus in a NICU that Routinely Vaccinates
4:12
Vaccine Completion and Timeliness Among Children in the Military Health System: 2010-2019
Vaccine Completion and Timeliness Among Children in the Military Health System: 2010-2019
3:45
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
3:43
Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine
Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine
4:12
Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State
Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State
4:10
Policy Approaches for Increasing Adolescent HPV Vaccination Coverage: A Systematic Review
Policy Approaches for Increasing Adolescent HPV Vaccination Coverage: A Systematic Review
4:21
Prior Infection and Effectiveness of COVID-19 Vaccination in Middle and High-School Students
Prior Infection and Effectiveness of COVID-19 Vaccination in Middle and High-School Students
4:09
Vaccine Mandates and Influenza Vaccination During the Pandemic
Vaccine Mandates and Influenza Vaccination During the Pandemic
4:11
Maternal Pertussis Vaccination, Infant Immunization, and Risk of Pertussis
Maternal Pertussis Vaccination, Infant Immunization, and Risk of Pertussis
4:15
Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety
Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety
4:11
Failure to Complete Multi-Dose Vaccine Series in Early Childhood
Failure to Complete Multi-Dose Vaccine Series in Early Childhood
4:12
Provider-Based HPV Vaccine Promotion Interventions: A Meta-analysis
Provider-Based HPV Vaccine Promotion Interventions: A Meta-analysis
4:03
Safety and Immunogenicity of Cell-based Quadrivalent Influenza Vaccine: A Randomized Trial
Safety and Immunogenicity of Cell-based Quadrivalent Influenza Vaccine: A Randomized Trial

Currently loaded videos are 1 through 15 of 48 total videos.

First page loaded, no previous page available
Load Next Page